Cinctive Capital Management LP - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cinctive Capital Management LP ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2022$18,000
-91.4%
19,565
-86.1%
0.00%
-87.5%
Q1 2022$210,000
-31.4%
140,9250.0%0.01%
-38.5%
Q4 2021$306,000
-67.7%
140,925
-47.1%
0.01%
-72.3%
Q3 2021$948,000
+3.3%
266,365
+66.5%
0.05%
+9.3%
Q2 2021$918,000160,0000.04%
Other shareholders
ONCOCYTE CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders